Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma

RS. Laskar, P. Li, S. Ecsedi, B. Abedi-Ardekani, G. Durand, N. Robinot, JN. Hubert, V. Janout, D. Zaridze, A. Mukeria, D. Mates, I. Holcatova, L. Foretova, B. Swiatkowska, Z. Dzamic, S. Milosavljevic, R. Olaso, A. Boland, JF. Deleuze, DC. Muller,...

. 2021 ; 30 (5) : 343-355. [pub] 20210427

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004433

Grantová podpora
U01 CA155309 NCI NIH HHS - United States
Cancer Research UK - United Kingdom

Sexual dimorphism in cancer incidence and outcome is widespread. Understanding the underlying mechanisms is fundamental to improve cancer prevention and clinical management. Sex disparities are particularly striking in kidney cancer: across diverse populations, men consistently show unexplained 2-fold increased incidence and worse prognosis. We have characterized genome-wide expression and regulatory networks of 609 renal tumors and 256 non-tumor renal tissues. Normal kidney displayed sex-specific transcriptional signatures, including higher expression of X-linked tumor suppressor genes in women. Sex-dependent genotype-phenotype associations unraveled women-specific immune regulation. Sex differences were markedly expanded in tumors, with male-biased expression of key genes implicated in metabolism, non-malignant diseases with male predominance and carcinogenesis, including markers of tumor infiltrating leukocytes. Analysis of sex-dependent RCC progression and survival uncovered prognostic markers involved in immune response and oxygen homeostasis. In summary, human kidney tissues display remarkable sexual dimorphism at the molecular level. Sex-specific transcriptional signatures further shape renal cancer, with relevance for clinical management.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004433
003      
CZ-PrNML
005      
20220127145238.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/hmg/ddab031 $2 doi
035    __
$a (PubMed)33527138
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Laskar, Ruhina S $u Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France
245    10
$a Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma / $c RS. Laskar, P. Li, S. Ecsedi, B. Abedi-Ardekani, G. Durand, N. Robinot, JN. Hubert, V. Janout, D. Zaridze, A. Mukeria, D. Mates, I. Holcatova, L. Foretova, B. Swiatkowska, Z. Dzamic, S. Milosavljevic, R. Olaso, A. Boland, JF. Deleuze, DC. Muller, JD. McKay, P. Brennan, F. Le Calvez-Kelm, G. Scelo, E. Chanudet
520    9_
$a Sexual dimorphism in cancer incidence and outcome is widespread. Understanding the underlying mechanisms is fundamental to improve cancer prevention and clinical management. Sex disparities are particularly striking in kidney cancer: across diverse populations, men consistently show unexplained 2-fold increased incidence and worse prognosis. We have characterized genome-wide expression and regulatory networks of 609 renal tumors and 256 non-tumor renal tissues. Normal kidney displayed sex-specific transcriptional signatures, including higher expression of X-linked tumor suppressor genes in women. Sex-dependent genotype-phenotype associations unraveled women-specific immune regulation. Sex differences were markedly expanded in tumors, with male-biased expression of key genes implicated in metabolism, non-malignant diseases with male predominance and carcinogenesis, including markers of tumor infiltrating leukocytes. Analysis of sex-dependent RCC progression and survival uncovered prognostic markers involved in immune response and oxygen homeostasis. In summary, human kidney tissues display remarkable sexual dimorphism at the molecular level. Sex-specific transcriptional signatures further shape renal cancer, with relevance for clinical management.
650    _2
$a senioři $7 D000368
650    _2
$a nádorové biomarkery $x metabolismus $7 D014408
650    _2
$a karcinom z renálních buněk $x genetika $x metabolismus $7 D002292
650    _2
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    12
$a stanovení celkové genové exprese $7 D020869
650    12
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a tumor supresorové geny $7 D016147
650    _2
$a geny vázané na chromozom X $7 D050172
650    _2
$a genetické asociační studie $7 D056726
650    12
$a genetická predispozice k nemoci $7 D020022
650    _2
$a celogenomová asociační studie $7 D055106
650    _2
$a lidé $7 D006801
650    _2
$a nádory ledvin $x genetika $x metabolismus $7 D007680
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prognóza $7 D011379
650    12
$a pohlavní dimorfismus $7 D012727
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Li, Peng $u Laboratory of Population Health, Max Planck Institute for Demographic Research, 18057 Rostock, Germany
700    1_
$a Ecsedi, Szilvia $u Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France
700    1_
$a Abedi-Ardekani, Behnoush $u Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France
700    1_
$a Durand, Geoffroy $u Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France
700    1_
$a Robinot, Nivonirina $u Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France
700    1_
$a Hubert, Jean-Noël $u Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France
700    1_
$a Janout, Vladimir $u Science and Research Center, Faculty of Health Sciences, Palacky University, 77900 Olomouc, Czech Republic
700    1_
$a Zaridze, David $u Department of Epidemiology and Prevention, Russian N.N. Blokhin Cancer Research Centre, 115478 Moscow, Russian Federation
700    1_
$a Mukeria, Anush $u Department of Epidemiology and Prevention, Russian N.N. Blokhin Cancer Research Centre, 115478 Moscow, Russian Federation
700    1_
$a Mates, Dana $u Department of Environmental Health, National Institute of Public Health, 050463 Bucharest, Romania
700    1_
$a Holcatova, Ivana $u Department of Public Health and Preventive Medicine, Charles University, Second Faculty of Medicine, 15006 Prague, Czech Republic
700    1_
$a Foretova, Lenka $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, 60200 Brno, Czech Republic
700    1_
$a Swiatkowska, Beata $u Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, 91-348 Lodz, Poland
700    1_
$a Dzamic, Zoran $u Clinic of Urology, Clinical Center of Serbia (KCS), University of Belgrade - Faculty of Medicine, 11000 Belgrade, Serbia
700    1_
$a Milosavljevic, Sasa $u International Organisation for Cancer Prevention and Research, 11070 Belgrade, Serbia
700    1_
$a Olaso, Robert $u Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, 91057, Evry, France
700    1_
$a Boland, Anne $u Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, 91057, Evry, France
700    1_
$a Deleuze, Jean-François $u Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, 91057, Evry, France
700    1_
$a Muller, David C $u Faculty of Medicine, School of Public Health, Imperial College London, W21NY London, UK
700    1_
$a McKay, James D $u Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France
700    1_
$a Brennan, Paul $u Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France
700    1_
$a Le Calvez-Kelm, Florence $u Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France
700    1_
$a Scelo, Ghislaine $u Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France $u Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, 8-10124 Turin, Italy
700    1_
$a Chanudet, Estelle $u Section of Genetics, International Agency for Research on Cancer (IARC-WHO), 69372 Lyon, France
773    0_
$w MED00002077 $t Human molecular genetics $x 1460-2083 $g Roč. 30, č. 5 (2021), s. 343-355
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33527138 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145235 $b ABA008
999    __
$a ok $b bmc $g 1751796 $s 1155582
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 30 $c 5 $d 343-355 $e 20210427 $i 1460-2083 $m Human molecular genetics $n Hum Mol Genet $x MED00002077
GRA    __
$a U01 CA155309 $p NCI NIH HHS $2 United States
GRA    __
$p Cancer Research UK $2 United Kingdom
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace